Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in CABG
NCT00246740Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Oct 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in reperfusion injury (IRI), sponsored by University of Alberta. Started Oct 2005; status: completed.
02
Drugs
doxycycline
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00246740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246740.